Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care.

Patrick BidulkaEdouard L FuClémence LeyratFotini KalogirouKatherine S L McAllisterEdward J KingdonKathryn E MansfieldMasao IwagamiLiam SmeethCatherine M ClaseKrishnan BhaskaranMerel van DiepenJuan-Jesus CarreroDorothea NitschLaurie A Tomlinson

Published in: BMC medicine (2020)

Previous ACEI/ARB users who continued treatment after an episode of AKI did not have an increased risk of heart failure or subsequent AKI compared to those who stopped the drugs.

Keyphrases

acute kidney injury
heart failure
cardiac surgery
healthcare
palliative care
clinical practice
left ventricular
angiotensin converting enzyme
combination therapy
cardiac resynchronization therapy
chronic pain
angiotensin ii